The Enterprise Value as of June 2026 (TTM) for Jounce Therapeutics, Inc. (JNCE) is -41597260.00

According to Jounce Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -41597260.00. This represents a change of -145.54% compared to the average of 91.34M of the last 4 quarters.

Jounce Therapeutics, Inc. (JNCE) Historical Enterprise Value (quarterly & annually)

How has JNCE Enterprise Value performed in the past?

The mean historical Enterprise Value of Jounce Therapeutics, Inc. over the last ten years is 241.64M. The current -41597260.00 Enterprise Value has changed -1821.49% with respect to the historical average. Over the past ten years (40 quarters), JNCE's Enterprise Value was at its highest in in the March 2018 quarter at 600.79M. The Enterprise Value was at its lowest in in the December 2022 quarter at -83191640.00.

Jounce Therapeutics, Inc. (JNCE) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Jounce Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Jounce Therapeutics, Inc. (JNCE) Average Enterprise Value

How has JNCE Enterprise Value performed in the past?

The current Enterprise Value of Jounce Therapeutics, Inc. (JNCE) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Jounce Therapeutics, Inc. (JNCE) Enterprise Value vs. Peers

How is JNCE’s Enterprise Value compared to its peers?

Jounce Therapeutics, Inc.’s Enterprise Value is less than HilleVax, Inc. (69.63M), less than Aadi Bioscience, Inc. (170.93M), less than Miromatrix Medical Inc. (91.30M), less than Insight Molecular Diagnostics Inc. (125.45M), less than Cyteir Therapeutics, Inc. (-37516738.00), less than Opiant Pharmaceuticals, Inc. (88.02M), less than RVL Pharmaceuticals plc (16.09M), less than Berkeley Lights, Inc. (42.64M), less than Tourmaline Bio, Inc. (1.20B), less than Decibel Therapeutics, Inc. (102.82M),

Build a custom stock screener for Jounce Therapeutics, Inc. (JNCE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Jounce Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Jounce Therapeutics, Inc. (JNCE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Jounce Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.